Stryker Reports Decline in Earnings; Beats Estimate (SYK)

Stryker Reports Decline in Earnings; Beats Estimate (SYK)


Medical product supplier, Stryker Corporation(SYK) reported declined profits on Thursday, but beat analysts estimates..

The Kalamazoo, MI based company reported fourth quarter net income of $270 million, or 71 cents per share, down -32% from $401 million, or $1.05 per share last year. Excluding special items, earnings were reported at $1.14 per share, beating analysts estimate of $1.12.

STK saw a 6% increase in revenue, coming in at $2.34 billion from $2.22 billion last year. Analysts expected revenue of $2.34 billion.

Included in the quarters revenue was a 7% growth to the company’s reconstructive products unit, and a 2% increase in its MedSurg equipment unit. SYK also saw a 10% upside from their neurotechnology and spine products.

The loss in profits was partially caused by a $133 million charge for the recall of hip implant devices.

The company expects to see 2013 earnings in the range of $4.25 to $4.40 per share. Analysts are expecting earnings of $4.31 per share.

Stryker shares were mostly flat during premarket trading Thursday. The stock has increased 16% in the past year.

The Bottom Line
Shares of Stryker (SYK) have a 1.71% dividend yield, based on last night’s closing stock price of $61.87. The stock has technical support in the $56 price area. If the shares can firm up, we see overhead resistance around the $64-$67 price levels.

Stryker Corporation(SYK)is not recommended at this time, holding a DARS™ Rating of 3.4 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.

Free Updates

Join over 100,000 investors who get the latest news from

Best Dividend Stocks

Looking for stocks that are poised for growth and pay solid dividends? Visit our list of the:

Best Dividend Stocks

Partner Center

Best CD Rates

Sitting on some extra cash and looking for the most current and profitable CD Rates?

Get The Best CD Rates

14 Day Free Trial

Earn more from your dividend portfolio within the next 14 days.

Sign Up Today